State Street Corp Altimmune, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Altimmune, Inc. stock. As of the latest transaction made, State Street Corp holds 3,413,827 shares of ALT stock, worth $26.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,413,827

Previous 3,909,286 12.67%

Holding current value

$26.5 Million

Previous $26 Million 19.37%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.5 - $8.1 $2.73 Million - $4.01 Million	-495,459 Reduced 12.67%	3,413,827 $21 Million
Q2 2024 Aug 14, 2024	SELL	$5.91 - $10.23 $28 Million - $48.5 Million	-4,739,984 Reduced 54.8%	3,909,286 $26 Million
Q1 2024 May 15, 2024	BUY	$8.22 - $13.81 $62.8 Million - $105 Million	7,634,724 Added 752.53%	8,649,270 $88 Million
Q4 2023 Feb 14, 2024	BUY	$2.14 - $11.62 $307,443 - $1.67 Million	143,665 Added 16.5%	1,014,546 $11.4 Million
Q3 2023 Nov 14, 2023	BUY	$2.4 - $3.45 $160,339 - $230,487	66,808 Added 8.31%	870,881 $2.26 Million
Q2 2023 Aug 14, 2023	SELL	$3.45 - $5.97 $14.3 Million - $24.8 Million	-4,155,181 Reduced 83.79%	804,073 $2.84 Million
Q1 2023 May 15, 2023	SELL	$4.19 - $16.83 $4 Million - $16.1 Million	-955,334 Reduced 16.15%	4,959,254 $20.9 Million
Q4 2022 Feb 14, 2023	BUY	$8.74 - $16.45 $22 Million - $41.4 Million	2,515,732 Added 74.02%	5,914,588 $97.3 Million
Q3 2022 Nov 15, 2022	BUY	$10.67 - $22.41 $34.8 Million - $73.1 Million	3,263,310 Added 2407.53%	3,398,856 $43.4 Million
Q2 2022 Aug 15, 2022	SELL	$3.94 - $11.77 $2.19 Million - $6.54 Million	-555,595 Reduced 80.39%	135,546 $1.59 Million
Q1 2022 May 16, 2022	SELL	$5.9 - $9.45 $22 Million - $35.3 Million	-3,730,400 Reduced 84.37%	691,141 $4.21 Million
Q4 2021 Feb 14, 2022	BUY	$8.69 - $12.48 $7.8 Million - $11.2 Million	897,523 Added 25.47%	4,421,541 $40.5 Million
Q3 2021 Nov 15, 2021	SELL	$8.43 - $16.81 $1.34 Million - $2.68 Million	-159,298 Reduced 4.32%	3,524,018 $39.9 Million
Q2 2021 Aug 16, 2021	BUY	$9.85 - $16.46 $7.3 Million - $12.2 Million	741,137 Added 25.19%	3,683,316 $36.3 Million
Q1 2021 May 17, 2021	BUY	$12.71 - $24.31 $37.4 Million - $71.5 Million	2,942,179 New	2,942,179 $41.6 Million

Others Institutions Holding ALT

# of Institutions

186

Shares Held

39.3M

Call Options Held

913K

Put Options Held

743K

View Full List

About Altimmune, Inc.

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $380M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

More about ALT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Altimmune, Inc. Transaction History